Lido Advisors LLC Acquires 14,768 Shares of Astera Labs, Inc. $ALAB

Lido Advisors LLC grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 114.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 27,630 shares of the company’s stock after buying an additional 14,768 shares during the quarter. Lido Advisors LLC’s holdings in Astera Labs were worth $9,836,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. Greenleaf Trust lifted its position in Astera Labs by 1.8% during the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after buying an additional 36 shares in the last quarter. Parkside Financial Bank & Trust grew its holdings in Astera Labs by 74.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after acquiring an additional 41 shares during the last quarter. Integrated Advisors Network LLC increased its position in Astera Labs by 4.8% in the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock valued at $350,000 after acquiring an additional 45 shares in the last quarter. Interchange Capital Partners LLC increased its position in Astera Labs by 4.4% in the 3rd quarter. Interchange Capital Partners LLC now owns 1,187 shares of the company’s stock valued at $423,000 after acquiring an additional 50 shares in the last quarter. Finally, Glenmede Trust Co. NA increased its position in Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after acquiring an additional 51 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Astera Labs News Roundup

Here’s some of the latest news about ALAB:

  • Neutral Sentiment: Astera Labs announced it will participate in the BMO Technology and Innovation Leaders Conference on Nov. 12. The announcement provides a forum for company updates but did not disclose new business or financial information. Conference announcement
  • Neutral Sentiment: A short-interest entry claims a large increase but reports total short interest of zero shares, making the data contradictory and unhelpful as a clear trading signal.
  • Negative Sentiment: Northland cut its FY2027 EPS forecast to $4.79 from $5.43 and lowered several quarterly 2027 estimates, including Q2–Q4. These reductions suggest a more cautious earnings outlook, despite the firm retaining its Outperform rating and $315 target. Analyst estimate details

Insider Activity

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the company’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $211.41, for a total transaction of $1,901,421.54. Following the transaction, the director owned 1,987 shares in the company, valued at approximately $420,071.67. The trade was a 81.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 408,558 shares of company stock worth $126,050,884. Corporate insiders own 10.40% of the company’s stock.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of research analyst reports. Royal Bank Of Canada dropped their target price on shares of Astera Labs from $500.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, November 4th. Wall Street Zen raised shares of Astera Labs from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Susquehanna lowered their price target on shares of Astera Labs from $310.00 to $258.00 and set a “neutral” rating for the company in a report on Wednesday, November 4th. Finally, Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price objective for the company in a research report on Wednesday, November 4th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $320.85.

Check Out Our Latest Analysis on ALAB

Astera Labs Stock Up 6.8%

Shares of ALAB opened at $230.91 on Thursday. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a market capitalization of $40.36 billion, a PE ratio of 92.00 and a beta of 3.85. The stock’s fifty day simple moving average is $296.41 and its 200-day simple moving average is $256.51.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.13. The business had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The firm’s quarterly revenue was up 153.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.49 earnings per share. Analysts anticipate that Astera Labs, Inc. will post 2.99 EPS for the current year.

About Astera Labs

(Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Recommended Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.